A study led by Dr.Ningli Wang and Dr.Yuan Xie (Beijing Tongren Hospital, Capital Medical University) provides evidence that retinal microvasculature is a potential biomarker for cerebral microvasculature changes and acute ...
Apr 7, 2023
0
2
A common heart feature long thought to have negligible effects on human health and performance may be problematic at high altitude, according to University of Oregon researchers.
Jun 30, 2015
0
29
For individuals with obstructive sleep apnea traveling to higher altitudes (which may exacerbate symptoms), use of a combination therapy resulted in improvement in symptoms including reduced insomnia and better control of ...
Dec 11, 2012
0
0
Nothing ruins a summer vacation faster than getting sick.
Jun 11, 2014
0
0
Equipped with the latest gear and a thirst for adventure, mountaineers embrace the perils that come with conquering the world's highest peaks. Yet, even those who tread more cautiously at high altitudes are not immune from ...
Mar 2, 2024
0
0
New magnetic resonance imaging (MRI) research shows that mountain climbers who experience a certain type of high altitude sickness have traces of bleeding in the brain years after the initial incident, according to a study ...
Nov 28, 2012
0
0
At high altitude, marked bilateral leakage of peripheral retinal vessels was observed in 7 of 14 participants (50 percent). All findings completely reversed after descent. "Retinal capillary leakage should be considered a ...
Jun 4, 2013
0
0
Working on a remote, barren peak in the Bolivian Andes, Ryan Paterson and his fellow emergency room doctors came face-to-face with everything from altitude sickness to appendicitis to complications of sickle cell anemia.
Sep 18, 2012
0
0
Afghanistan's geography is dominated by a collection of craggy peaks, the highest—a mountain known as Noshaq—has been measured to 7,492 meters. Consequently, the soldiers on duty in this mountainous terrain must often ...
Apr 21, 2013
0
0
A new study published in Wilderness & Environmental Medicine demonstrated that trekkers and climbers taking a lower dose of acetazolamide (62.5 mg twice daily) were no more likely to develop acute mountain sickness (AMS) ...
Mar 11, 2019
0
0
